Australia, Sept. 16 -- DEKA Research & Development Corp., owns the trademark (2407835) for 'SEQUEL' till Aug. 18, 2033.
Status: protected:
Registered/protected
Classes: 5 [Infusion cartridges sold pre-filled with medication for medical use in the field of cardiovascular disease, diabetes, asthma, kidney disease, and cancer; adhesive overlays in the nature of adhesive medical tape and adhesive bandages for use with infusion pumps and associated devices, all of the foregoing for use in connection with a device for the delivery of therapeutic agents for the treatment of disease, and none of the foregoing for use in connection with parasitic preparations.], 9 [Software as a Medical Device (SaMD), downloadable, for predicting blood analyte lev...